#1810
FOXM1 Is Strongly Associated with Cell Proliferation and Is Not Influenced by Metabolic Syndrome in GEP-NETS
Introduction:
Gastro-entero-pancreatic neuroendocrine tumors(GEP-NETs) and metabolic syndrome(MS) are both increasing exponentially. MS has been associated with several non NET cancers.
Conference:
14th Annual ENETSConcerence (2017)
Presenting Author:
Pereira R
Authors:
Pereira R,
Pereira S,
Morais T,
Costa M,
Sampaio P,
Keywords:
GEP-NETs,
metabolic syndrome,
FOXM1,
IGF1R,
IL-6,
Ki67 ,
#1039
Receptor Tyrosine-Kinases Inhibition: New Insights on Therapeutic Implications of EGFR and IGF1R in Human Bronchopulmonary NET
Introduction:
The main treatment for bronchopulmonary NET(BP-NET) is surgery, which is not feasible for infiltrating and metastatic disease, where medical therapy is tried. Identifying new therapeutic targets is important to provide adequate medical treatment for patients with BP-NET. Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor (TKI), is mainly described to inhibit VEGF
Conference:
12th Annual ENETSConcerence (2015)
Presenting Author:
Gagliano T
Authors:
Gagliano T,
Benfini K,
Gentilin E,
Falletta S,
Di Pasquale C,
Keywords:
RTK,
BP-NET,
IGF1R,
EGFR,